Next 10 |
home / stock / gtsif / gtsif news
Vancouver, British Columbia--(Newsfile Corp. - November 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: LOBEF) (" Lobe " or the " Company ") today announced that its common stock ticker will change from "GTSIF" to "LOBEF" and will commence trading under the symbol "LOBEF" in US markets a...
Vancouver, British Columbia--(Newsfile Corp. - November 8, 2021) - Lobe Sciences (OTC Pink: GTSIF) today announced that Philip Young, CEO & Director will be attending the Q4 Virtual Investor Summit. Millions of people are experiencing the devastating, often long-term effects of mTBI (m...
Six Thought Leaders Across Arts, Technology, Academic and Industry Sectors to Advise on the Krysalistm Pod Immersive Treatment Experience Vancouver, British Columbia--(Newsfile Corp. - October 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (" Lobe " or the " Company ") today...
Vancouver, British Columbia--(Newsfile Corp. - October 5, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (" Lobe " or the " Company ") today announced that Philip Young, CEO and Director, will present virtually at the BioFuture 2021 Conference taking place October 5-6, 2021, and will...
Plans to Develop and Launch A Global Registry For The Identification and Long Term Management of Current and Former Boxers With mTBI and PTSD Insights Derived From This Project Will Help Guide The Development Of Guidelines and Treatment Goals For The WBA Family Vancouver, British Columbi...
Lobe Sciences Announces Data Demonstrating That Its Combination Therapeutic Candidates are Significantly More Effective Than Monotherapy in mTBI and PTSD PR Newswire Combination Therapy with Psilocybin plus NAC (N-Acetylcysteine) Is Statistically Significantly Better T...
Vancouver, British Columbia--(Newsfile Corp. - September 27, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (" Lobe " or the " Company ") today announced that Philip Young, CEO and Director, will present virtually at the Benzinga Healthcare Small Cap Conference taking place September...
Lobe Sciences (OTC: GTSIF) is a life sciences company focused on psychedelic medicines. The company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechani...
Vancouver, British Columbia--(Newsfile Corp. - September 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (" Lobe " or the " Company ") today announced that Philip Young, CEO and Director, will participate in a round table discussion at the Advances in Mental Health Psychedelics an...
Vancouver, British Columbia--(Newsfile Corp. - September 13, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (" Lobe " or the " Company ") is pleased to provide the following corporate update by CEO Philip Young, addressed to shareholders, investors and other stakeholders of the Compa...
News, Short Squeeze, Breakout and More Instantly...
Greenstar Biosciences Corp Company Name:
GTSIF Stock Symbol:
OTCMKTS Market:
Vancouver, British Columbia--(Newsfile Corp. - November 15, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: LOBEF) (" Lobe " or the " Company ") today announced that its common stock ticker will change from "GTSIF" to "LOBEF" and will commence trading under the symbol "LOBEF" in US markets a...
Vancouver, British Columbia--(Newsfile Corp. - November 8, 2021) - Lobe Sciences (OTC Pink: GTSIF) today announced that Philip Young, CEO & Director will be attending the Q4 Virtual Investor Summit. Millions of people are experiencing the devastating, often long-term effects of mTBI (m...
Six Thought Leaders Across Arts, Technology, Academic and Industry Sectors to Advise on the Krysalistm Pod Immersive Treatment Experience Vancouver, British Columbia--(Newsfile Corp. - October 6, 2021) - Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (" Lobe " or the " Company ") today...